Detail akcie PolyPid Rg online

Business Summary: Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Polypid Ltd revenues was not reported. Net loss increased 25% to $25.7M. Higher net loss reflects General and administrative increase of 66% to $5.4M (expense), Research and development increase of 11% to $17.6M (expense), Marketing and business development increase of 90% to $1.4M (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$3.85 to -$1.85.